What does LIPELLA PHARMACEUTICALS INC. (LIPO) do?

LIPELLA PHARMACEUTICALS INC. (LIPO) is a publicly traded company.

What sector does LIPO operate in?

LIPELLA PHARMACEUTICALS INC. operates in the equity market. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find LIPO earnings analysis?

AlphaOS publishes an earnings intelligence page for LIPELLA PHARMACEUTICALS INC. (LIPO) covering results, guidance context, and AI-assisted analysis. See /stocks/LIPO/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 55%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

LIPO

LIPELLA PHARMACEUTICALS INC.

$2.36Jun 17, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

LIPELLA PHARMACEUTICALS INC. shows decelerating business momentum based on AlphaOS pipeline evidence.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Pipeline evidence · 2d ago

LIPO's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on LIPO.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2025

Full LIPO earnings analysis

Reported figures for LIPELLA PHARMACEUTICALS INC. — research only, not investment advice.

Revenue YoY: -36.4%

Latest Intelligence

Updated September 28, 2026

What happened recently for LIPELLA PHARMACEUTICALS INC. (LIPO) — events, not interpretation.

Event: Reported Q2 2025 revenue -36% YoY.
Also: Last session June 17, 2026 at $2.36.
Source: Q2 2025 earnings

Research & analysis only — not investment advice.

Building company intelligence…

LIPELLA PHARMACEUTICALS INC. (LIPO)

US equity research on AlphaOS

Investment Snapshot above is the primary AlphaOS analysis for LIPELLA PHARMACEUTICALS INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:: $10.91M
Revenue:: $536,357

LIPO earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow LIPELLA PHARMACEUTICALS INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.